Adagio Medical Holdings, Inc. - SIC # 3841 - SURGICAL AND MEDICAL INSTRUMENTS AND APPARATUS

Ticker Exchange SIC # Website Latest Ticker
ADGM Nasdaq 3841 adagiomedical.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Adagio Medical Holdings, Inc.

Adagio Medical Appoints Two Seasoned Senior Executives to Accelerate Commercial Readiness - Dec 22nd, 2025 6:00 am
Adagio Medical Appoints Industry Veteran Sean Salmon to Board of Directors - Dec 11th, 2025 6:00 am
Adagio Medical Reports Third Quarter 2025 Results - Nov 12th, 2025 2:05 pm
Adagio Medical to Present at the Piper Sandler 37th Annual Healthcare Conference - Nov 5th, 2025 6:00 am
Adagio Medical Closes Financing of $19 Million Upfront; Positions Company to Advance Purpose-Built Technology for Treatment of Ventricular Tachycardia - Oct 20th, 2025 6:00 am
Adagio Medical Announces Pricing of up to $50 Million Private Placement of Securities - Oct 15th, 2025 6:00 am
Adagio Medical Unveils Preliminary Acute Results from FULCRUM-VT U.S. Pivotal Study in Late Breaking Session at VT Symposium - Oct 10th, 2025 1:40 pm
Adagio Medical, Inc. Announces Completion of Enrollment for FULCRUM-VT Pivotal Clinical Trial Evaluating Ultra-Low Temperature Cryoablation for Ventricular Tachycardia - Oct 1st, 2025 6:00 am
Adagio Medical FULCRUM-VT U.S. Pivotal Study Acute Results to be Presented in Late-Breaking Session at VT Symposium - Sep 18th, 2025 6:00 am
Adagio Medical Expands Chief Business Officer Deborah Kaster’s Role to Include Chief Financial Officer Responsibilities - Sep 8th, 2025 6:00 am
Adagio Medical Reports Second Quarter 2025 Results - Aug 13th, 2025 2:30 pm
Adagio Medical Reports First Quarter 2025 Results - May 15th, 2025 2:05 pm
Adagio Medical to Present at the BofA Securities 2025 Health Care Conference - May 7th, 2025 6:30 am
Adagio Medical Holdings, Inc. Receives FDA Breakthrough Device Designation for the vCLASTM Cryoablation System - Apr 17th, 2025 6:30 am
Adagio Medical Appoints Deborah Kaster as Chief Business Officer - Mar 31st, 2025 2:01 pm
Adagio Medical Reports Fourth Quarter and Full Year 2024 Results - Mar 31st, 2025 6:30 am
Adagio Medical Holdings Reports Full Year 2024 Earnings - Mar 29th, 2025 7:21 am
Adagio Medical Provides Clinical and Business Updates - Mar 17th, 2025 2:01 pm
Adagio Medical Announces Strategic Restructuring to Accelerate US Pivotal IDE Trial and Product Innovation - Feb 28th, 2025 6:30 am